SEC Form 4 · accession 0001171843-16-007714
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward S. Ahn
Officer — Chief Tech & Strategy Officer
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 4, 2016 | A | 7,900 | $0.00 | A | 7,900 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $38.11 | Feb 4, 2016 | A | 18,300 | A | — | Feb 4, 2026 | Common Stock | 18,300 | 18,300 | D |
Explanation of responses
- F1Restricted stock awards vest in four equal annual installments beginning February 4, 2017.
- F2The stock options vest in four equal annual installments beginning February 4, 2017.